BioMarin Announces Data Analysis Demonstrating Consistent Efficacy of Kyndrisa™ (drisapersen) in Comparable Patients Across Three Randomized Studies
Go back to BioMarin Announces Data Analysis Demonstrating Consistent Efficacy of Kyndrisa™ (drisapersen) in Comparable Patients Across Three Randomized Studies| BioMarin Pharmaceuticals, Inc. (NASDAQ: BMRN) | Delayed: 55.56 +0.87 (1.59%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $54.69 | 52 Week High | $108.96 | |||
| Open | $55.51 | 52 Week Low | $62.12 | |||
| Day High | $55.88 | P/E | N/A | |||
| Day Low | $54.96 | EPS | $-1.27 | |||
| Volume | 1,332,950 | |||||
